[Pfizer Inc.](https://www.pfizer.com)

April 28, 2026

$5,000–$250,000 per project (up to $500,000 total available); project length up to ~18 months

Supports education for healthcare teams on best practices and targeted therapies in metastatic prostate cancer, focusing on guideline-driven care, testing, and PARP inhibitor management.

--- ## Description This grant program from Pfizer Inc. funds independent medical education initiatives aimed at healthcare professionals involved in the care of patients with metastatic prostate cancer (mPC), including both mCSPC and mCRPC disease states. The goal is to address educational gaps in the optimal application and management of targeted therapies, particularly the integration of testing into clinical practice, understanding the efficacy and safety of PARP inhibitors (PARPi) and their combinations, best practices for mitigating side effects, and strategies to implement genetic testing workflows. The program also emphasizes the importance of multidisciplinary care teams and patient engagement in treatment decisions and clinical trial participation. Projects must be evidence-based and aligned with current guidelines, ultimately seeking to improve patient outcomes. --- ## Due Dates - Submission deadline: April 28, 2026 (by 23:59 Eastern Standard Time) Applications submitted after the due date will not be reviewed. --- ## Funding Amount - Individual project requests: $5,000 – $250,000 - Total available funding for this RFP: $500,000 - Maximum project duration: Approximately 18 months - Overhead costs capped at 28% of the total proposed budget (per Pfizer policy) - Award amounts include direct, indirect, and allowable institutional overhead costs --- ## Eligibility - **Eligible applicants:** - Medical, dental, nursing, allied health, and pharmacy professional schools - Healthcare institutions (large and small) - Professional organizations/medical societies - Medical education companies - Other entities with a mission related to healthcare professional education or improvement - **Not eligible:** - Individuals - Independent medical practice groups not affiliated with a hospital, academic institution, or professional society - **Additional requirements:** - Only organizations legally able to receive direct funding from Pfizer may apply - The project/program lead must be an employee or contractor of the applicant organization - For projects offering continuing education credit, the applicant must be an accredited provider - Multi-institutional projects must clearly define each institution’s role --- ## Application Process - Applications must be submitted online via the [Pfizer CyberGrants portal](http://www.cybergrants.com/pfizer/knowledge) - First-time users must create a password before the deadline - Select “Start A New Knowledge Gap Application” - For “Competitive Grant?” select “Yes” - Primary Area of Interest: “Oncology- Genitourinary- KG” - Competitive Grant Program Name: “2026 ONC US mPC Best Practices IME” - Upload a single-spaced project proposal (Calibri 12-point font, 1-inch margins, max 15 pages excluding references) - Required proposal sections include: - Goals and objectives - Assessment of need - Target audience description - Project design and methods - Innovation - Evaluation and outcomes - Dissemination plan - Anticipated timeline - Organization detail and partner roles - Detailed budget narrative - Only complete applications submitted via the designated portal will be accepted --- ## Additional Information - Projects evaluating the efficacy of therapeutic or diagnostic agents (i.e., clinical research) will not be considered - The grant supports independent education only; Pfizer will not participate in project development or execution - All applicants will be notified of funding decisions by May 19, 2026 - Anticipated project start: June/July 2026; end date: December 31, 2027 - A written grant agreement with Pfizer is required for funded projects - Overhead costs must not exceed 28% of the total budget --- ## External Links - [Full RFP PDF](https://cdn.pfizer.com/pfizercom/2026-03/2026-ONC-US-mPC-BestPractices-IME.pdf?VersionId=xhuIYIvROtk7zJX4RbIHCfGjLqXkV5Uc) - [Pfizer Inc. homepage](https://www.pfizer.com) - [Pfizer CyberGrants application portal](http://www.cybergrants.com/pfizer/knowledge) --- ## Contact Information | Contact | Email | Phone | Notes | |----------------------|-----------------------------------------|------------------|--------------------------------------| | Lori Carpenter (Grant Officer) | [lori.carpenter@pfizer.com](mailto:lori.carpenter@pfizer.com) | 1-800-879-3477 | Subject line: “2026 ONC US mPC Best Practices” | | Pfizer General Contact | [Contact form](https://www.pfizer.com/contact) | 1-800-879-3477 | For general inquiries |

Pfizer Independent Medical Education Grant Request for Proposals: Prostate Cancer Best Practices for Combining Targeted Therapies in mPC

Sign in to see full grant listing